GGrantIndex
← Leaderboards

Edward W Harhaj

University Of Miami School Of Medicine

$12,325,910
Attributed
$12,325,910
Total exposure
11
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,325,910 · 11

By mechanism

R01$9,137,496 · 5
R21$2,183,178 · 5
P01$1,005,236 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Transcription Factor

Research focus

Transcription FactorPlayGenesSignal TransductionProteinsPhosphotransferasesSignal PathwayInsightAutomobile DrivingInvestigationMediatingCytokineMolecularBaseCellsRegulationPrincipal InvestigatorPathway InteractionsGene ExpressionResponseViralPhosphorylationNf-Kappa BTaxes

Grant awards (42)

ZFAND6 regulation of mitophagy and inflammation$707,534
R01 · FY2025 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$627,318
R01 · FY2025 · AI · contact PI
Regulation of the cGAS-STING pathway by RNF11$425,004
R21 · FY2025 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$627,318
R01 · FY2024 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$72,543
R01 · FY2024 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$627,318
R01 · FY2023 · AI · contact PI
KDR/VEGFR2 regulation of HTLV-1 oncogenesis and viral gene expression$202,950
R21 · FY2023 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$66,777
R01 · FY2023 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$627,318
R01 · FY2022 · AI · contact PI
KDR/VEGFR2 regulation of HTLV-1 oncogenesis and viral gene expression$243,540
R21 · FY2022 · AI · contact PI
AIP inhibition of IRF7 and innate antiviral signaling$199,810
R21 · FY2022 · AI · contact PI
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1$642,863
R01 · FY2021 · AI · contact PI
AIP inhibition of IRF7 and innate antiviral signaling$230,994
R21 · FY2021 · AI · contact PI
ZFAND6 regulation of innate antiviral immunity$197,900
R21 · FY2021 · AI · contact PI
ZFAND6 regulation of innate antiviral immunity$237,480
R21 · FY2020 · AI · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$275,940
R01 · FY2018 · CA · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$291,600
R01 · FY2017 · CA · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$291,600
R01 · FY2016 · CA · contact PI
The role of TAX1BP1 in the innate immune response to virus infection$202,500
R21 · FY2016 · AI · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$291,600
R01 · FY2015 · CA · contact PI
The role of TAX1BP1 in the innate immune response to virus infection$243,000
R21 · FY2015 · AI · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$291,600
R01 · FY2014 · CA · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$245,201
R01 · FY2013 · CA · contact PI
Disruption of Antiviral Signaling Pathways by HTLV-I Tax$188,594
P01 · FY2013 · CA · contact PI
Negative regulation of NF-kB and inflammation by TAX1BP1$309,614
R01 · FY2012 · GM · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$260,852
R01 · FY2012 · CA · contact PI
Disruption of Antiviral Signaling Pathways by HTLV-I Tax$200,997
P01 · FY2012 · CA · contact PI
Negative regulation of NF-kB and inflammation by TAX1BP1$292,414
R01 · FY2011 · GM · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$246,361
R01 · FY2011 · CA · contact PI
Disruption of Antiviral Signaling Pathways by HTLV-I Tax$198,979
P01 · FY2011 · CA · contact PI
Negative regulation of NF-kB and inflammation by TAX1BP1$295,367
R01 · FY2010 · GM · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$253,980
R01 · FY2010 · CA · contact PI
Disruption of Antiviral Signaling Pathways by HTLV-I Tax$209,107
P01 · FY2010 · CA · contact PI
Negative regulation of NF-kB and inflammation by TAX1BP1$298,350
R01 · FY2009 · GM · contact PI
Mechanisms of HTLV-I Tax-mediated NF-kB activation$253,980
R01 · FY2009 · CA · contact PI
Disruption of Antiviral Signaling Pathways by HTLV-I Tax$207,559
P01 · FY2009 · CA · contact PI
HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration$238,817
R01 · FY2007 · CA · contact PI
HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration$245,950
R01 · FY2006 · CA · contact PI
HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration$251,869
R01 · FY2005 · CA
HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration$251,869
R01 · FY2004 · CA
HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration$224,372
R01 · FY2003 · CA
HTLV Deregulation of CD40(L) in Cancer&Neurodegeneration$27,171
R01 · FY2003 · CA